Gps Wealth Strategies Group, LLC Sarepta Therapeutics, Inc. Transaction History

Gps Wealth Strategies Group, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 12, 2024	SELL	$67.31 - $124.76 $11,375 - $21,084	-169 Reduced 48.99%	176 $16,000
Q3 2023 Oct 25, 2023	SELL	$102.5 - $123.59 $5,740 - $6,921	-56 Reduced 13.97%	345 $41,000
Q1 2023 Apr 17, 2023	BUY	$117.53 - $155.99 $47,129 - $62,551	401 New	401 $55,000
Q2 2022 Jul 19, 2022	SELL	$62.69 - $88.44 $2,068 - $2,918	-33 Reduced 7.6%	401 $30,000
Q1 2022 Apr 20, 2022	SELL	$63.15 - $90.42 $2,526 - $3,616	-40 Reduced 8.44%	434 $34,000
Q3 2021 Oct 20, 2021	BUY	$65.97 - $92.48 $1,385 - $1,942	21 Added 4.64%	474 $44,000
Q2 2021 Jul 19, 2021	BUY	$69.38 - $86.75 $31,429 - $39,297	453 New	453 $35,000

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Gps Wealth Strategies Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Gps Wealth Strategies Group, LLC with notifications on news.